High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.
about
High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
High competing risks minimize ...... : a population-based analysis.
@en
High competing risks minimize ...... : a population-based analysis.
@nl
type
label
High competing risks minimize ...... : a population-based analysis.
@en
High competing risks minimize ...... : a population-based analysis.
@nl
prefLabel
High competing risks minimize ...... : a population-based analysis.
@en
High competing risks minimize ...... : a population-based analysis.
@nl
P2093
P2860
P356
P1433
P1476
High competing risks minimize ...... a: a population-based analysis
@en
P2093
Girish S Kulkarni
Neil E Fleshner
Rashid K Sayyid
Zachary Klaassen
P2860
P304
16731-16743
P356
10.18632/ONCOTARGET.24675
P407
P577
2018-03-30T00:00:00Z